期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Expression, purification and evaluation of N-terminal domain of AcAP5 with Factor Xa inhibitory activity
1
作者 刘爱华 朱元军 +1 位作者 刘晓岩 王银叶 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2013年第3期268-271,共4页
Ancylostoma anticoagulant peptide 5 (AcAP5) is a strong inhibitor of human coagulation factor Xa (FXa). The N-terminal residues (N40) of AcAP5 contains a domain that could combine with FXa. In order to determine... Ancylostoma anticoagulant peptide 5 (AcAP5) is a strong inhibitor of human coagulation factor Xa (FXa). The N-terminal residues (N40) of AcAP5 contains a domain that could combine with FXa. In order to determine whether N40 protein has FXa inhibitory effect, we cloned, expressed and purified the protein for activity evaluation. The DNA fragment coding N40 was amplified by PCR, cloned into pET-30a to construct recombinant plasmid pET30a-N40, and subsequently transformed into E. coli, BL21 (DE3). Expression of N40 was induced by isopropyl ~3-D-l-thiogalactopyranoside (IPTG), and the interest protein was identified by SDS-PAGE and purified using one-step nickel (Ni) affinity chromatography. Under the optimal expres- sion condition (0.05 mM IPTG for 6 h at 37 ℃), the purity of N40 reached 90%. We also evaluated the inhibition activity of N40 protein on FXa, finding the ICso was 4.58× 10 5 mol/L, This study suggests the N40 of AcAP5 could combine with FXa to inhibit FXa activity. 展开更多
关键词 AcAP5 fxa binding domain fxa inhibition EXPRESSION PURIFICATION
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部